LAMEA Microbiome Diagnostics Market Size, Share & Trends Analysis Report By Application, By Product (Reagents & Kits and Instruments), By Sample (Fecal, Saliva, Skin, and Others), By Technology, By End User, By Country and Growth Forecast, 2023

List of Tables

The Latin America, Middle East and Africa Microbiome Diagnostics Market would witness market growth of 21.2% CAGR during the forecast period (2023-2030).

The Brazil market dominated the LAMEA Microbiome Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $7,003.2 Thousands by 2030. The Argentina market is experiencing a CAGR of 21.9% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 20.8% during (2023 - 2030).

It has applications in women's health, particularly in understanding the vaginal microbiota and its implications for reproductive health and gynecological conditions. Perturbations in the vaginal microbiome are associated with conditions such as bacterial vaginosis, urinary tract infections, and preterm birth. It enables the characterization of the vaginal microbiome and identification of microbial biomarkers predictive of adverse outcomes, guiding personalized interventions and preventive measures.

Also, chronic diseases such as diabetes, cancer, inflammatory bowel diseases (IBD), and asthma are associated with alterations in the microbiome composition. For example, according to Statistics Canada, in 2021, 45.1% of Canadians had at least one serious chronic illness. In 2021, around 2.5 million Canadians reported having unmet healthcare needs. Similarly, according to Eurostat, in 2022, over one-third (36.1%) of EU citizens stated that they had a long-standing (chronic) health issue. As the prevalence of these chronic conditions rises, there is a growing demand for microbiome diagnostics to assess microbial imbalances, identify disease biomarkers, and personalize treatment approaches.

The expansion of the healthcare sector in Saudi Arabia will likely drive demand for microbiome diagnostics as clinicians seek to integrate these innovative tools into diagnostic workflows to improve patient outcomes. According to the International Trade Administration (ITA), Saudi Arabia contributes 60% of the healthcare expenditures of the Gulf Cooperation Council (GCC) nations, and the Saudi Arabian government continues to prioritize this sector. The nation spent $50.4 billion on healthcare and social development in 2023, representing 16.96 percent of its budget and ranking second only to education in terms of expenditure. Thus, the rising healthcare sector and growing proportion of elderly in the region drive the market's growth.

Based on Application, the market is segmented into Disease Diagnostics (Gastrointestinal Disorders, Metabolic Diseases and Others) and Research Application. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Sample, the market is segmented into Fecal, Saliva, Skin, and Others. Based on Technology, the market is segmented into 16S rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics and Others. Based on End User, the market is segmented into Hospitals, Academic & Research Institutes, and Biotechnology & Pharmaceutical Companies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

Illumina, Inc.
Becton, Dickinson and Company
Genetic Analysis AS
Microba Life Sciences Limited
BioMe Oxford Ltd
Viome Life Sciences, Inc.
GoodGut S.L.U. (HIPRA, S.A.)
Sun Genomics
Origin Sciences Limited
Decode Age

LAMEA Microbiome Diagnostics Market Report Segmentation

By Application

Disease Diagnostics
- Gastrointestinal Disorders
- Metabolic Diseases
- Others
Research Application

By Product

Reagents & Kits
Instruments

By Sample

Fecal
Saliva
Skin
Others

By Technology

16S rRNA Sequencing
Shot Gun Metagenomics
Metatranscriptomics
Others

By End User

Hospitals
Academic & Research Institutes
Biotechnology & Pharmaceutical Companies

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1LAMEA Microbiome Diagnostics Market, by Application
- 1.4.2LAMEA Microbiome Diagnostics Market, by Product
- 1.4.3LAMEA Microbiome Diagnostics Market, by Sample
- 1.4.4LAMEA Microbiome Diagnostics Market, by Technology
- 1.4.5LAMEA Microbiome Diagnostics Market, by End User
- 1.4.6LAMEA Microbiome Diagnostics Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
3.3Porter Five Forces Analysis

Chapter 4.Strategies Deployed in Microbiome Diagnostics Market

Chapter 5.LAMEA Microbiome Diagnostics Market by Application

5.1LAMEA Disease Diagnostics Market by Country
5.2LAMEA Microbiome Diagnostics Market by Disease Diagnostics Type
- 5.2.1LAMEA Gastrointestinal Disorders Market by Country
- 5.2.2LAMEA Metabolic Diseases Market by Country
- 5.2.3LAMEA Others Market by Country
5.3LAMEA Research Application Market by Country

Chapter 6.LAMEA Microbiome Diagnostics Market by Product

6.1LAMEA Reagents & Kits Market by Country
6.2LAMEA Instruments Market by Country

Chapter 7.LAMEA Microbiome Diagnostics Market by Sample

7.1LAMEA Fecal Market by Country
7.2LAMEA Saliva Market by Country
7.3LAMEA Skin Market by Country
7.4LAMEA Others Market by Country

Chapter 8.LAMEA Microbiome Diagnostics Market by Technology

8.1LAMEA 16S rRNA Sequencing Market by Country
8.2LAMEA Shot Gun Metagenomics Market by Country
8.3LAMEA Metatranscriptomics Market by Country
8.4LAMEA Others Market by Country

Chapter 9.LAMEA Microbiome Diagnostics Market by End User

9.1LAMEA Hospitals Market by Country
9.2LAMEA Academic & Research Institutes Market by Country
9.3LAMEA Biotechnology & Pharmaceutical Companies Market by Country

Chapter 10.LAMEA Microbiome Diagnostics Market by Country

10.1Brazil Microbiome Diagnostics Market
- 10.1.1Brazil Microbiome Diagnostics Market by Application
  - 10.1.1.1Brazil Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.1.2Brazil Microbiome Diagnostics Market by Product
- 10.1.3Brazil Microbiome Diagnostics Market by Sample
- 10.1.4Brazil Microbiome Diagnostics Market by Technology
- 10.1.5Brazil Microbiome Diagnostics Market by End User
10.2Argentina Microbiome Diagnostics Market
- 10.2.1Argentina Microbiome Diagnostics Market by Application
  - 10.2.1.1Argentina Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.2.2Argentina Microbiome Diagnostics Market by Product
- 10.2.3Argentina Microbiome Diagnostics Market by Sample
- 10.2.4Argentina Microbiome Diagnostics Market by Technology
- 10.2.5Argentina Microbiome Diagnostics Market by End User
10.3UAE Microbiome Diagnostics Market
- 10.3.1UAE Microbiome Diagnostics Market by Application
  - 10.3.1.1UAE Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.3.2UAE Microbiome Diagnostics Market by Product
- 10.3.3UAE Microbiome Diagnostics Market by Sample
- 10.3.4UAE Microbiome Diagnostics Market by Technology
- 10.3.5UAE Microbiome Diagnostics Market by End User
10.4Saudi Arabia Microbiome Diagnostics Market
- 10.4.1Saudi Arabia Microbiome Diagnostics Market by Application
  - 10.4.1.1Saudi Arabia Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.4.2Saudi Arabia Microbiome Diagnostics Market by Product
- 10.4.3Saudi Arabia Microbiome Diagnostics Market by Sample
- 10.4.4Saudi Arabia Microbiome Diagnostics Market by Technology
- 10.4.5Saudi Arabia Microbiome Diagnostics Market by End User
10.5South Africa Microbiome Diagnostics Market
- 10.5.1South Africa Microbiome Diagnostics Market by Application
  - 10.5.1.1South Africa Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.5.2South Africa Microbiome Diagnostics Market by Product
- 10.5.3South Africa Microbiome Diagnostics Market by Sample
- 10.5.4South Africa Microbiome Diagnostics Market by Technology
- 10.5.5South Africa Microbiome Diagnostics Market by End User
10.6Nigeria Microbiome Diagnostics Market
- 10.6.1Nigeria Microbiome Diagnostics Market by Application
  - 10.6.1.1Nigeria Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.6.2Nigeria Microbiome Diagnostics Market by Product
- 10.6.3Nigeria Microbiome Diagnostics Market by Sample
- 10.6.4Nigeria Microbiome Diagnostics Market by Technology
- 10.6.5Nigeria Microbiome Diagnostics Market by End User
10.7Rest of LAMEA Microbiome Diagnostics Market
- 10.7.1Rest of LAMEA Microbiome Diagnostics Market by Application
  - 10.7.1.1Rest of LAMEA Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.7.2Rest of LAMEA Microbiome Diagnostics Market by Product
- 10.7.3Rest of LAMEA Microbiome Diagnostics Market by Sample
- 10.7.4Rest of LAMEA Microbiome Diagnostics Market by Technology
- 10.7.5Rest of LAMEA Microbiome Diagnostics Market by End User

Chapter 11.Company Profiles

11.1Illumina, Inc.
- 11.1.1Company Overview
- 11.1.2Financial Analysis
- 11.1.3Regional Analysis
- 11.1.4Research & Development Expense
- 11.1.5Recent strategies and developments:
  - 11.1.5.1Partnerships, Collaborations, and Agreements:
- 11.1.6SWOT Analysis
11.2Becton, Dickinson, and Company
- 11.2.1Company Overview
- 11.2.2Financial Analysis
- 11.2.3Segmental and Regional Analysis
- 11.2.4Research & Development Expense
- 11.2.5Recent strategies and developments:
  - 11.2.5.1Product Launches and Product Expansions:
  - 11.2.5.2Trails and Approvals:
- 11.2.6SWOT Analysis
11.3Genetic Analysis AS
- 11.3.1Company Overview
- 11.3.2Financial Analysis
- 11.3.3Regional Analysis
- 11.3.4Recent strategies and developments:
  - 11.3.4.1Partnerships, Collaborations, and Agreements:
11.4Microba Life Sciences Limited
- 11.4.1Company Overview
- 11.4.2Financial Analysis
- 11.4.3Regional Analysis
- 11.4.4Research & Development Expenses
- 11.4.5Recent strategies and developments:
  - 11.4.5.1Partnerships, Collaborations, and Agreements:
  - 11.4.5.2Product Launches and Product Expansions:
11.5BioMe Oxford Ltd
- 11.5.1Company Overview
- 11.5.2Recent strategies and developments:
  - 11.5.2.1Partnerships, Collaborations, and Agreements:
11.6Viome Life Sciences, Inc.
- 11.6.1Company Overview
- 11.6.2Recent strategies and developments:
  - 11.6.2.1Product Launches and Product Expansions:
  - 11.6.2.2Acquisition and Mergers:
11.7GoodGut S.L.U. (HIPRA, S.A.)
- 11.7.1Company Overview
11.8Sun Genomics
- 11.8.1Company Overview
11.9Origin Sciences Limited
- 11.9.1Company Overview
11.10.Decode Age
- 11.10.1Company Overview

LIST OF TABLES

TABLE 1LAMEA Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 2LAMEA Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 3LAMEA Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 4LAMEA Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 5LAMEA Disease Diagnostics Market by Country, 2019 - 2022, USD Thousands
TABLE 6LAMEA Disease Diagnostics Market by Country, 2023 - 2030, USD Thousands
TABLE 7LAMEA Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 8LAMEA Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 9LAMEA Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Thousands
TABLE 10LAMEA Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Thousands
TABLE 11LAMEA Metabolic Diseases Market by Country, 2019 - 2022, USD Thousands
TABLE 12LAMEA Metabolic Diseases Market by Country, 2023 - 2030, USD Thousands
TABLE 13LAMEA Others Market by Country, 2019 - 2022, USD Thousands
TABLE 14LAMEA Others Market by Country, 2023 - 2030, USD Thousands
TABLE 15LAMEA Research Application Market by Country, 2019 - 2022, USD Thousands
TABLE 16LAMEA Research Application Market by Country, 2023 - 2030, USD Thousands
TABLE 17LAMEA Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 18LAMEA Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 19LAMEA Reagents & Kits Market by Country, 2019 - 2022, USD Thousands
TABLE 20LAMEA Reagents & Kits Market by Country, 2023 - 2030, USD Thousands
TABLE 21LAMEA Instruments Market by Country, 2019 - 2022, USD Thousands
TABLE 22LAMEA Instruments Market by Country, 2023 - 2030, USD Thousands
TABLE 23LAMEA Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 24LAMEA Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 25LAMEA Fecal Market by Country, 2019 - 2022, USD Thousands
TABLE 26LAMEA Fecal Market by Country, 2023 - 2030, USD Thousands
TABLE 27LAMEA Saliva Market by Country, 2019 - 2022, USD Thousands
TABLE 28LAMEA Saliva Market by Country, 2023 - 2030, USD Thousands
TABLE 29LAMEA Skin Market by Country, 2019 - 2022, USD Thousands
TABLE 30LAMEA Skin Market by Country, 2023 - 2030, USD Thousands
TABLE 31LAMEA Others Market by Country, 2019 - 2022, USD Thousands
TABLE 32LAMEA Others Market by Country, 2023 - 2030, USD Thousands
TABLE 33LAMEA Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 34LAMEA Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 35LAMEA 16S rRNA Sequencing Market by Country, 2019 - 2022, USD Thousands
TABLE 36LAMEA 16S rRNA Sequencing Market by Country, 2023 - 2030, USD Thousands
TABLE 37LAMEA Shot Gun Metagenomics Market by Country, 2019 - 2022, USD Thousands
TABLE 38LAMEA Shot Gun Metagenomics Market by Country, 2023 - 2030, USD Thousands
TABLE 39LAMEA Metatranscriptomics Market by Country, 2019 - 2022, USD Thousands
TABLE 40LAMEA Metatranscriptomics Market by Country, 2023 - 2030, USD Thousands
TABLE 41LAMEA Others Market by Country, 2019 - 2022, USD Thousands
TABLE 42LAMEA Others Market by Country, 2023 - 2030, USD Thousands
TABLE 43LAMEA Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 44LAMEA Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 45LAMEA Hospitals Market by Country, 2019 - 2022, USD Thousands
TABLE 46LAMEA Hospitals Market by Country, 2023 - 2030, USD Thousands
TABLE 47LAMEA Academic & Research Institutes Market by Country, 2019 - 2022, USD Thousands
TABLE 48LAMEA Academic & Research Institutes Market by Country, 2023 - 2030, USD Thousands
TABLE 49LAMEA Biotechnology & Pharmaceutical Companies Market by Country, 2019 - 2022, USD Thousands
TABLE 50LAMEA Biotechnology & Pharmaceutical Companies Market by Country, 2023 - 2030, USD Thousands
TABLE 51LAMEA Microbiome Diagnostics Market by Country, 2019 - 2022, USD Thousands
TABLE 52LAMEA Microbiome Diagnostics Market by Country, 2023 - 2030, USD Thousands
TABLE 53Brazil Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 54Brazil Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 55Brazil Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 56Brazil Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 57Brazil Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 58Brazil Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 59Brazil Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 60Brazil Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 61Brazil Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 62Brazil Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 63Brazil Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 64Brazil Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 65Brazil Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 66Brazil Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 67Argentina Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 68Argentina Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 69Argentina Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 70Argentina Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 71Argentina Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 72Argentina Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 73Argentina Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 74Argentina Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 75Argentina Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 76Argentina Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 77Argentina Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 78Argentina Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 79Argentina Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 80Argentina Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 81UAE Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 82UAE Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 83UAE Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 84UAE Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 85UAE Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 86UAE Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 87UAE Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 88UAE Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 89UAE Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 90UAE Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 91UAE Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 92UAE Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 93UAE Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 94UAE Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 95Saudi Arabia Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 96Saudi Arabia Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 97Saudi Arabia Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 98Saudi Arabia Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 99Saudi Arabia Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 100Saudi Arabia Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 101Saudi Arabia Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 102Saudi Arabia Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 103Saudi Arabia Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 104Saudi Arabia Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 105Saudi Arabia Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 106Saudi Arabia Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 107Saudi Arabia Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 108Saudi Arabia Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 109South Africa Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 110South Africa Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 111South Africa Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 112South Africa Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 113South Africa Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 114South Africa Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 115South Africa Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 116South Africa Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 117South Africa Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 118South Africa Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 119South Africa Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 120South Africa Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 121South Africa Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 122South Africa Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 123Nigeria Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 124Nigeria Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 125Nigeria Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 126Nigeria Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 127Nigeria Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 128Nigeria Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 129Nigeria Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 130Nigeria Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 131Nigeria Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 132Nigeria Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 133Nigeria Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 134Nigeria Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 135Nigeria Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 136Nigeria Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 137Rest of LAMEA Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 138Rest of LAMEA Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 139Rest of LAMEA Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 140Rest of LAMEA Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 141Rest of LAMEA Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 142Rest of LAMEA Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 143Rest of LAMEA Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 144Rest of LAMEA Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 145Rest of LAMEA Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 146Rest of LAMEA Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 147Rest of LAMEA Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 148Rest of LAMEA Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 149Rest of LAMEA Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 150Rest of LAMEA Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 151key information - Illumina, Inc.
TABLE 152Key Information - Becton, Dickinson and Company
TABLE 153Key Information - Genetic Analysis AS
TABLE 154Key Information - Microba Life Sciences Limited
TABLE 155Key Information -BioMe Oxford Ltd
TABLE 156Key Information - Viome Life Sciences, Inc.
TABLE 157Key Information - GoodGut S.L.U.
TABLE 158Key Information - Sun Genomics
TABLE 159Key Information - Origin Sciences Limited
TABLE 160Key Information - Decode Age

LAMEA Microbiome Diagnostics Market Size, Share & Trends Analysis Report By Application, By Product (Reagents & Kits and Instruments), By Sample (Fecal, Saliva, Skin, and Others), By Technology, By End User, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents